Gene: VSIG10L
Official Full Name: V-set and immunoglobulin domain containing 10 likeprovided by HGNC
Gene Summary: Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23686 | VSIG10L Knockout cell line (HeLa) | Human | VSIG10L | 1:3~1:6 | Negative | Online Inquiry |
KO23687 | VSIG10L Knockout cell line (HCT 116) | Human | VSIG10L | 1:2~1:4 | Negative | Online Inquiry |
KO23688 | VSIG10L Knockout cell line (A549) | Human | VSIG10L | 1:3~1:4 | Negative | Online Inquiry |
VSIG10L Gene Knockout Cell Lines are meticulously engineered cellular models that allow for the targeted disruption of the VSIG10L gene, a key player in numerous biological processes including immune cell signaling and tissue homeostasis. By employing CRISPR/Cas9 gene editing technology, these knockout lines provide researchers with a powerful tool to investigate the gene's functional role in various physiological and pathological contexts.
The primary function of VSIG10L Gene Knockout Cell Lines lies in their ability to elucidate the biological consequences of VSIG10L gene ablation. The absence of this gene can profoundly affect signaling pathways involved in immune response and cellular adhesion, enabling scientists to study alterations in cell behavior, proliferation, and interaction with surrounding microenvironments. These cell lines facilitate controlled experiments that can lead to a better understanding of diseases, particularly those related to immune dysregulation or cancer.
The scientific importance of VSIG10L Gene Knockout Cell Lines is underscored by their broad applicability in both research and clinical settings. They serve as invaluable models for drug discovery, biomarker identification, and the development of therapeutic interventions. Furthermore, their use in investigating host-pathogen interactions makes them particularly suited for studies related to infectious diseases and inflammatory conditions.
What sets these knockout cell lines apart from alternative systems is not only the precision of CRISPR/Cas9 technology but also the quality assurance processes inherent in their development. Each line undergoes rigorous validation to confirm successful gene knockout and functional characterization, thus ensuring reliability and reproducibility in experimental outcomes. Researchers can trust that these cell lines will yield consistent results across diverse studies.
The value of VSIG10L Gene Knockout Cell Lines extends to both researchers and clinicians by providing indispensable insights into complex biological systems. They help bridge the gap between basic research and clinical applications, ensuring that findings can be translated into effective diagnostics and therapies.
Our company specializes in the development of advanced biological products, combining cutting-edge technology with extensive expertise. We are dedicated to providing researchers with high-quality, reliable tools that empower innovation and drive scientific progress.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.